Actively Recruiting
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Led by Indiana University · Updated on 2026-05-07
62
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
Sponsors
I
Indiana University
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to test CGM ASSIST. This is a digital tool that uses an interactive information display-an easy-to-read screen designed to help people with dementia (or memory loss) and diabetes, as well as their caregivers and doctors. Managing diabetes is often difficult for people with memory issues. This study uses a Continuous Glucose Monitor (CGM), which is a device that tracks blood sugar levels in real-time. CGM ASSIST adds a new way to see this data through interactive displays. These displays show clear information and medical guidelines to help patients and caregivers make sense of the glucose readings. The study aims to: * Increase Awareness: Help patients and caregivers recognize the dangers of low blood sugar (hypoglycemia) and how to treat it. * Improve Teamwork: Encourage "shared decision-making," where patients, caregivers, and doctors work together to make health choices. * Test Feasibility: See if it is easy and helpful for people with memory loss to use these interactive displays in their daily lives. * Understand Experiences: Learn how the thoughts and feelings of patients and families affect how they manage diabetes. By using these interactive displays, the researchers hope to make it easier for families to understand their health needs and communicate better with their medical team. Participants will: * Answer a survey about how they manage their diabetes * Learn how to use a Continuous Glucose Monitor and wear it for 14 days * Answer 3 brief telephone surveys during these 14 days * Complete a clinic visit with their doctor and answer a final survey on how this visit went using the CGM ASSIST report
CONDITIONS
Official Title
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient must have both mild cognitive impairment or Alzheimer's disease and diabetes
- Patient must have active diabetes prescriptions
- Patient must have visited an Eskenazi or IU Health primary care clinic in the past 12 months
- Patient must be able to give assent and have a legally authorized representative consent if needed
- Patient must have a caregiver aged 18 or older who interacts daily or almost daily
- Both patient and caregiver must speak English
- Both patient and caregiver must live in the community
- The patient-caregiver pair must have internet access
You will not qualify if you...
- Patient has a terminal illness
- Patient uses an automated insulin delivery system
- Patient is receiving dialysis
- Patient is taking ascorbic acid during monitoring
- Patient has implanted medical devices
- Patient has a bleeding disorder
- Patient has existing arm skin lesions
- Patient is allergic to medical adhesive or isopropyl alcohol
- Patient has planned imaging or diathermy treatment during the study
- Clinician treats only patients younger than 65
- Clinician does not manage patients with diabetes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eskenazi Health
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Research Team
A
April Savoy, PhD
CONTACT
N
Nina Johnson, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here